How Pharma Companies Can Optimize Clinical Trial Operations and Unlock Value
Clinical trials are complex yet integral to the pharmaceutical and biotechnology industries' ability to develop innovative new products. However, lack of program governance, approval delays, and limited integration of technological systems can adversely impact cost, quality, and time.
What can these organizations do to overcome these obstacles?